Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix - PubMed (original) (raw)
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix
K Heselmeyer et al. Proc Natl Acad Sci U S A. 1996.
Abstract
We have chosen tumors of the uterine cervix as a model system to identify chromosomal aberrations that occur during carcinogenesis. A phenotype/genotype correlation was established in defined regions of archived, formalin-fixed, and hematoxylin/eosin-stained tissue sections that were dissected from normal cervical epithelium (n = 3), from mild (n = 4), moderate (n = 6), and severe dysplasias/carcinomas in situ (CIS) (n = 13), and from invasive carcinomas (n = 10) and investigated by comparative genomic hybridization. The same tissues were analyzed for DNA ploidy, proliferative activity, and the presence of human papillomavirus (HPV) sequences. The results show that an increase in proliferative activity and tetraploidization had occurred already in mildly dysplastic lesions. No recurrent chromosomal aberrations were observed in DNA extracted from normal epithelium or from mild and moderate dysplasias, indicating that the tetraploidization precedes the loss or gain of specific chromosomes. A gain of chromosome 3q became visible in one of the severe dysplasias/CIS. Notably, chromosome 3q was overrepresented in 90% of the carcinomas and was also found to have undergone a high-level copy-number increase (amplification). We therefore conclude that the gain of chromosome 3q that occurs in HPV16-infected, aneuploid cells represents a pivotal genetic aberration at the transition from severe dysplasia/CIS to invasive cervical carcinoma.
Similar articles
- Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
Hopman AH, Theelen W, Hommelberg PP, Kamps MA, Herrington CS, Morrison LE, Speel EJ, Smedts F, Ramaekers FC. Hopman AH, et al. J Pathol. 2006 Dec;210(4):412-9. doi: 10.1002/path.2070. J Pathol. 2006. PMID: 17054308 - Cervical cytology by means of fluorescence in situ hybridization with a set of chromosome-specific DNA probes.
Hariu H, Matsuta M. Hariu H, et al. J Obstet Gynaecol Res. 1996 Apr;22(2):163-70. doi: 10.1111/j.1447-0756.1996.tb00960.x. J Obstet Gynaecol Res. 1996. PMID: 8697347 - Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q.
Heselmeyer K, Macville M, Schröck E, Blegen H, Hellström AC, Shah K, Auer G, Ried T. Heselmeyer K, et al. Genes Chromosomes Cancer. 1997 Aug;19(4):233-40. Genes Chromosomes Cancer. 1997. PMID: 9258658 - Cytogenetics of carcinoma of the cervix uteri: a review.
Atkin NB. Atkin NB. Cancer Genet Cytogenet. 1997 May;95(1):33-9. doi: 10.1016/s0165-4608(97)83452-8. Cancer Genet Cytogenet. 1997. PMID: 9140451 Review. - Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation.
Ried T, Heselmeyer-Haddad K, Blegen H, Schröck E, Auer G. Ried T, et al. Genes Chromosomes Cancer. 1999 Jul;25(3):195-204. doi: 10.1002/(sici)1098-2264(199907)25:3<195::aid-gcc1>3.0.co;2-8. Genes Chromosomes Cancer. 1999. PMID: 10379865 Review.
Cited by
- Impact of genomic stability on protein expression in endometrioid endometrial cancer.
Lomnytska MI, Becker S, Gemoll T, Lundgren C, Habermann J, Olsson A, Bodin I, Engström U, Hellman U, Hellman K, Hellström AC, Andersson S, Mints M, Auer G. Lomnytska MI, et al. Br J Cancer. 2012 Mar 27;106(7):1297-305. doi: 10.1038/bjc.2012.67. Epub 2012 Mar 13. Br J Cancer. 2012. PMID: 22415234 Free PMC article. - Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.
Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, Wang ZY, Auer G, Steinberg W, Ried T. Heselmeyer-Haddad K, et al. Am J Pathol. 2005 Apr;166(4):1229-38. doi: 10.1016/S0002-9440(10)62341-3. Am J Pathol. 2005. PMID: 15793301 Free PMC article. - Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancer.
Van Arsdale A, Patterson NE, Maggi EC, Agoni L, Van Doorslaer K, Harmon B, Nevadunsky N, Kuo DYS, Einstein MH, Lenz J, Montagna C. Van Arsdale A, et al. Genes Chromosomes Cancer. 2020 Feb;59(2):84-95. doi: 10.1002/gcc.22799. Epub 2019 Sep 4. Genes Chromosomes Cancer. 2020. PMID: 31407403 Free PMC article. - Chromosomal changes during development and progression of prostate adenocarcinomas.
Zitzelsberger H, Engert D, Walch A, Kulka U, Aubele M, Höfler H, Bauchinger M, Werner M. Zitzelsberger H, et al. Br J Cancer. 2001 Jan;84(2):202-8. doi: 10.1054/bjoc.2000.1533. Br J Cancer. 2001. PMID: 11161378 Free PMC article. - Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.
Chang CY, Shipony Z, Lin SG, Kuo A, Xiong X, Loh KM, Greenleaf WJ, Crabtree GR. Chang CY, et al. Mol Cell. 2021 Dec 16;81(24):4964-4978.e8. doi: 10.1016/j.molcel.2021.10.005. Epub 2021 Oct 22. Mol Cell. 2021. PMID: 34687603 Free PMC article.
References
- Hum Mol Genet. 1993 Nov;2(11):1907-14 - PubMed
- Cancer. 1994 Feb 1;73(3):664-71 - PubMed
- Cancer Res. 1994 Feb 1;54(3):637-9 - PubMed
- J Infect Dis. 1994 Feb;169(2):235-40 - PubMed
- Cancer Res. 1994 Apr 1;54(7):1801-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical